Harmony Biosciences
Harmony Biosciences, based in Plymouth Meeting, PA, focuses on developing treatments for rare neurological diseases, including their FDA-approved drug WAKIX for narcolepsy.
Services
Harmony Biosciences specializes in developing and delivering treatments for rare neurological diseases. They are focused on addressing the needs of individuals with these conditions, through innovative therapies and programs designed to improve patient outcomes.
Location
Harmony Biosciences is located at 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462. This serves as the headquarters for their operations, where they manage research, development, and commercialization activities.
Products
Harmony Biosciences offers a key product named WAKIX (pitolisant). WAKIX is utilized for the treatment of narcolepsy, a chronic sleep disorder. In addition, they are evaluating pitolisant for other neurological diseases, such as idiopathic hypersomnia, Prader-Willi syndrome, and myotonic dystrophy. The company is also developing HBS-102, an investigational compound aimed at treating a variety of rare neurological diseases.
Partnerships
Harmony Biosciences holds an exclusive license from Bioprojet, enabling the company to develop, manufacture, and commercialize pitolisant in the United States. This partnership underpins their efforts in bringing new neurological treatments to market.
Patient Support Programs
Harmony Biosciences runs the 'Patients at the Heart' program. This initiative is dedicated to supporting the needs of individuals with rare neurological disorders. It aims to enhance patient care and address the unique challenges faced by this population.